The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts or mixture thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
本发明涉及式(I)化合物:或其药学上可接受的盐或混合物,可抑制
丝氨酸蛋白酶活性,特别是丙型肝炎病毒
NS3-NS4A
蛋白酶的活性。